Skip to main content

Curaleaf Holdings, Inc. (CURLF)

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Last price
$8.48
As of

Kresmion compiles this page from CURLF's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.

Curaleaf Holdings, Inc. (CURLF): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-10-28.

As of . Source: SEC EDGAR filings for CURLF. Method and limitations.

COMPANY DOSSIER

See the full CURLF dossier

Price with insider and filing markers, who is positioning, fundamentals and peers for CURLF on one page. Preview it with sample data, then open it live with a free account.

Preview the CURLF dossier

Active events for CURLF

  • mediumEarnings above estimates

    Q2-2026: Beat consensus by 126.9%, EPS $0.05 vs $-0.186 estimate

  • mediumEarnings above estimates

    Q3-2025: Beat consensus by 5.4% - EPS $-0.21 vs $-0.2219 estimate

  • mediumEarnings above estimates

    Q4-2025: Beat consensus by 56.5% - EPS $-0.09 vs $-0.2069 estimate

  • mediumEarnings above estimates

    Q1-2026: Beat consensus by 217.6% - EPS $0.27 vs $-0.2295 estimate

  • mediumEarnings above estimates

    Beat consensus by 56.5% - EPS $-0.09 vs $-0.2069 estimate

FREE, NO ACCOUNT

Every event on CURLF, as it fires

You are seeing 5 of 9 events recorded on CURLF since 2026-05-30.

The five above landed across 3 days. The other 4 were recorded on 1 other days.

Get it by email

No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.

Join on Telegram
Join on Telegram

One tap. Live alerts, no email needed.

No non-option holdings from tracked managers in this reporting quarter. Historical quarters remain available above.

Recent SEC filings, CURLF

CURLF against its peers

CURLF's operating margin of 2.0% ranks in the 52nd percentile of 19 Drug Manufacturers - Specialty & Generic sub-industry peers, fiscal periods ending between 2025-03-31 and 2026-06-30.

MetricCURLFPeer medianPercentilen
Revenue FY1.3B USD586M USD8819
Revenue YoY-5.6%12.1%255
Gross margin49.8%54.1%4020
Operating margin2.0%-0.4%5319
Net margin-18.2%-5.3%2620
Return on equity-30.6%-7.5%1917

Peers (22): PBH, PRGO, HCM, TRLV, ALVO, ETON, GTBIF, RGC, CRON, INDV, HROW, KNSA, AQST, EOLS, KMDA, ELAN, RDY, VREOF, TLRY, TKNO, NIKA, VRNO. Left out: HYPMY (no annual filing), EVO (period gap), SGIOF (no annual filing). Fiscal periods ending between 2025-03-31 and 2026-06-30. Every figure is one full fiscal year read from one annual filing (CURLF: 40-F), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.

Related tickers

Follow CURLF on a live board

Kresmion is a cross-asset market-intelligence terminal. Open a board scoped to CURLF for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.

Preview the CURLF dossier
Share

The CURLF intelligence card: the smart money composite, cross family confluence and the top current signal, with a link back to this page.